The synthetic biology market can be segmented into 4 major categories: synthetic biology market by products, synthetic biology market by enabled product application, synthetic biology technology by enabling technology and synthetic biology by geography. The global synthetic biology market by enabling technology was valued at USD 183.84 million and is expected to grow at a CAGR of 44.7% from 2012 to 2018, to reach an estimated value of USD 1780.40 million by 2018.
Some of the key market players in the synthetic biology market are NEB, Amyris Biotechnology Inc, Blue Heron Biotechnology Inc, Chromatin, Febit Symbio GmbH, Gene Art-Life Science Technologies, Synthetic Genomics, Verdezyne Inc, New England Biolabs Inc, and others.
This research is specially designed to estimate and analyze the demand and performance of synthetic biology products in global scenario. This research provides in-depth analysis of Synthetic biology product manufacturers, product sales, trend analysis by segments and demand by geography.
Browse Bolg : Business Research Industry
The report covers all the major product segments of the global Synthetic biology market and provides in-depth analysis, historical data and statistically refined forecast for the segments covered. The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the global Synthetic biology market as below:
Synthetic Biology Market by P
Copyright©2012 Vocus, Inc.
All rights reserved